Trial
NCT04322305
Pregabalin Trial for the Treatment of Alcohol Use Disorder
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Alcohol Use Disorder
Intervention
Pregabalin
Why stopped
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-14